Recovery of renal function in black South African patients with malignant hypertension: Superiority of continuous ambulatory peritoneal dialysis over hemodialysis

Peritoneal Dialysis International

Volumn 21, Issue 6, 2001, Pages 581-586

  Katz, Ivor J ^a   Sofianou, Lana ^a   Butler, Omar ^a   Hopley, Mark ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Africa; Malignant hypertension; Recovery of renal function

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NIFEDIPINE; PERINDOPRIL; PRAZOSIN;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HEMODIALYSIS; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY SIZE; KIDNEY TRANSPLANTATION; MALE; MALIGNANT HYPERTENSION; MEAN ARTERIAL PRESSURE; MEDICAL RECORD; NEGRO; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SOUTH AFRICA; TIME; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; URINE VOLUME;

EID: 0035697890     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080102100608     Document Type: Article

References (30)

1. The malignant phase of essential hypertension in Johannesburg blacks
2. The pathological basis of end-stage renal disease in blacks
3. Race and end-stage renal disease
4. Hypertension as a cause of end-stage renal disease in South Africa
5. The clinical presentation of malignant hypertension in Nigerians
6. Malignant hypertension and its renal complications in black South Africans
7. Does renal function improve after the diagnosis of malignant phase hypertension?
8. Malignant arterial hypertension. Relationship between blood pressure control and renal function during long-term observation of patients with malignant nephrosclerosis
9. Recovery from anuria due to malignant hypertension
10. Acute oliguric renal failure due to accelerated (malignant) hypertension
11. Recovery from prolonged renal failure in patients with accelerated hypertension
12. Reversible renal failure in malignant hypertension
13. Recovery in malignant hypertension presenting as acute renal failure
14. Recovery of renal function in patients with accelerated malignant nephrosclerosis on maintenance dialysis with management of blood pressure by captopril
15. Partial recovery of renal function in black patients with apparent end-stage renal failure due to primary malignant hypertension
16. Transient and sustained recovery from renal shutdown in accelerated hypertension
17. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy
18. Renovascular hypertension in black patients
19. Selection criteria for chronic dialysis
20. Comparison of hemoglobin levels and blood-transfusion requirements in patients on hemodialysis and on chronic ambulatory peritoneal dialysis
21. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease
22. Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: Implications for dialysis hypotension
23. Effects of acetate and bicarbonate dialysate in stable chronic dialysis patients
24. The renal histopathology of essential malignant hypertension in black South Africans
25. Malignant arterial hypertension. Relationship between blood pressure control and renal function during long-term observation of patients with malignant nephrosclerosis
26. Hypertension in chronic-renal failure: An abnormal relation between sodium and the rennin-angiotensin system
27. Three cases of malignant hypertension: The roles of endothelin-1 and the renin-angiotensin-aldosterone system
28. Hemodialysis versus continuous ambulatory peritoneal dialysis: Effects on the heart
29. Expression of 90-kDa heat shock protein within regenerative tubular cells in a patient with acute oliguric renal failure due to malignant hypertension
30. Dialysis therapy